Glycorex Transplantation AB (NGM:GTAB B) Current Deferred Revenue : kr0.00 Mil (As of Dec. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Glycorex Transplantation AB Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Glycorex Transplantation AB's current deferred revenue for the quarter that ended in Dec. 2024 was kr0.00 Mil.

Glycorex Transplantation AB Current Deferred Revenue Historical Data

The historical data trend for Glycorex Transplantation AB's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glycorex Transplantation AB Current Deferred Revenue Chart

Glycorex Transplantation AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Deferred Revenue

Get a 7-Day Free Trial

Glycorex Transplantation AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Current Deferred Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Glycorex Transplantation AB Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Glycorex Transplantation AB's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Glycorex Transplantation AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

O33:Germany

Address

Solvegatan 41, Lund, SWE, 223 70

Website

http://www.glycorex.se

Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Glycorex Transplantation AB Headlines

No Headlines